References
- Ahn HY, Kim M, Chae JS, Ahn YT, Sim JH, Choi ID, et al. 2015. Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia. Atherosclerosis 241: 649-656. https://doi.org/10.1016/j.atherosclerosis.2015.06.030
- An HY, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, et al. 2011. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 10: 116. https://doi.org/10.1186/1476-511X-10-116
- Andrade S, Borges N. 2009. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J. Dairy Res. 76: 469-474. https://doi.org/10.1017/S0022029909990173
- Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F. 2009. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab. 54: 22-27. https://doi.org/10.1159/000203284
- Caussy C, Charrière S, Marçais C, Di Filippo M, Sassolas A, Delay M, et al. 2014. An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am. J. Hum. Genet. 94: 129-134. https://doi.org/10.1016/j.ajhg.2013.12.001
- Charlton-Menys V, Durrington PN. 2005. Apolipoprotein A5 and hypertriglyceridemia. Clin. Chem. 51: 295-297. https://doi.org/10.1373/clinchem.2004.044826
- Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
- Fruchart-Najib J, Baugé E, Niculescu LS, Pham T, Thomas B, Rommens C, et al. 2004. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem. Biophys. Res. Commun. 319: 397-404. https://doi.org/10.1016/j.bbrc.2004.05.003
- Fuentes MC, Lajo T, Carrión JM, Cuñé J. 2013. Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. Br. J. Nutr. 109: 1866-1872. https://doi.org/10.1017/S000711451200373X
- Guardiola M, Cofán M, de Castro-Oros I, Cenarro A, Plana N, Talmud PJ, et al. 2015. APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis. Atherosclerosis 240: 98-104 https://doi.org/10.1016/j.atherosclerosis.2015.03.008
- Hegele RA. 2009. Plasma lipoproteins: genetic influences and clinical implications. Nat. Rev. Genet. 10: 109-121. https://doi.org/10.1038/nrg2481
- Miremadia F, Ayyashb M, Sherkatc F, Stojanovskaa L. 2014. Cholesterol reduction mechanisms and fatty acid composition of cellular membranes of probiotic lactobacilli and bifidobacteria. J. Funct. Foods 9: 295-305. https://doi.org/10.1016/j.jff.2014.05.002
- Moroti C, Souza Magri LF, de Rezende Costa M, Cavallini DC, Sivieri K. 2012. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. 11: 29. https://doi.org/10.1186/1476-511X-11-29
- Park DY, Ahn YT, Huh CS, McGregor RA, Choi MS. 2013. Dual probiotic strains suppress high fructose-induced metabolic syndrome. World J. Gastroenterol. 19: 274-283. https://doi.org/10.3748/wjg.v19.i2.274
- Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, et al. 2013. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 8: e59470. https://doi.org/10.1371/journal.pone.0059470
- Pejic RN, Lee DT. 2006. Hypertriglyceridemia. J. Am. Board Fam. Med. 19: 310-316. https://doi.org/10.3122/jabfm.19.3.310
- Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173. https://doi.org/10.1126/science.1064852
- Prieur X, Coste H, Rodriguez JC. 2003. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J. Biol. Chem. 278: 25468-25480. https://doi.org/10.1074/jbc.M301302200
- Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. 2000. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 66: 2263-2266. https://doi.org/10.1128/AEM.66.5.2263-2266.2000
- Sharma V, Forte TM, Ryan RO. 2013. Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol. Curr. Opin. Lipidol. 24: 153-159. https://doi.org/10.1097/MOL.0b013e32835c8c1a
- Sharma V, Ryan RO, Forte TM. 2012. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement. Biochim. Biophys. Acta 1821: 795-799. https://doi.org/10.1016/j.bbalip.2011.12.002
- van den Berg SA, Heemskerk MM, Geerling JJ, van Klinken JB, Schaap FG, Bijland S, et al. 2013. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake. FASEB J. 27: 3354-3362. https://doi.org/10.1096/fj.12-225367
- van der Vliet HN, Schaap FG, Levels JH, Ottenhoff R, Looije N, Wesseling JG, et al. 2002. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem. Biophys. Res. Commun. 295: 1156-1159. https://doi.org/10.1016/S0006-291X(02)00808-2
- Vu-Dac N, Gervois P, Jakel H, Nowak M, Bauge E, Dehondt H, et al. 2003. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J. Biol. Chem. 278: 17982-17985. https://doi.org/10.1074/jbc.M212191200
- Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP. 2001. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67: 2578-2885. https://doi.org/10.1128/AEM.67.6.2578-2585.2001
- Yoo SR, Kim YJ, Park DY, Jung UJ, Jeon SM, Ahn YT, et al. 2013. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity 21: 2571-2578. https://doi.org/10.1002/oby.20428
Cited by
- INTERRELATIONSHIP OF THE PRO-INFLAMMATORY MARKER HSCRP WITH DYSLIPIDEMIC CHANGES: A COMPARATIVE STUDY BETWEEN SUBCLINICAL AND OVERT HYPOTHYROIDISM vol.5, pp.16, 2016, https://doi.org/10.14260/jemds/2016/186
- Probiotic Characteristics of Lactobacillus curvatus DN317, a Strain Isolated from Chicken Ceca vol.9, pp.4, 2016, https://doi.org/10.1007/s12602-017-9301-y
- Dietary lipid content reorganizes gut microbiota and probiotic L . rhamnosus attenuates obesity and enhances catabolic hormonal milieu in zebrafish vol.7, pp.None, 2016, https://doi.org/10.1038/s41598-017-05147-w
- Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo vol.9, pp.None, 2016, https://doi.org/10.3389/fmicb.2018.00530
- Effects of Lactobacillus Plantarum and Lactobacillus Helveticus on Renal Insulin Signaling, Inflammatory Markers, and Glucose Transporters in High-Fructose-Fed Rats vol.55, pp.5, 2016, https://doi.org/10.3390/medicina55050207
- Inhibitory Effects of Lactobacillus plantarum Q180 on Lipid Accumulation in HepG2 Cells vol.32, pp.6, 2016, https://doi.org/10.9799/ksfan.2019.32.6.738
- Protective Effect of Fermented Camel Milk Containing Bifidobacterium longum BB536 on Blood Lipid Profile in Hypercholesterolemic Rats vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/1557945
- Two putative probiotic strains improve diet‐induced hypercholesterolemia through modulating intestinal cholesterol uptake and hepatic cholesterol efflux vol.132, pp.1, 2016, https://doi.org/10.1111/jam.15181